Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Hinge Health (HNGE) Cost of Revenue (2024 - 2026)

Hinge Health's Cost of Revenue history spans 2 years, with the latest figure at $26.7 million for Q4 2025.

  • On a quarterly basis, Cost of Revenue rose 26.13% to $26.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $258.6 million, a N/A change, with the full-year FY2025 number at $119.6 million, up 32.19% from a year prior.
  • Cost of Revenue hit $26.7 million in Q4 2025 for Hinge Health, down from $63.5 million in the prior quarter.
  • Over the last five years, Cost of Revenue for HNGE hit a ceiling of $147.2 million in Q2 2025 and a floor of $21.2 million in Q4 2024.